Answers are grounded in this paper and cite their sources.
Consuming probiotics has a remarkable positive impact on gut health and helps prevent gastrointestinal disorders. This strategy offers the alluring advantage of longevity and a feeling of overall well-being. Lactic acid bacteria have dominated the majority of probiotic formulations up until this point. Their gastrointestinal tract sustainability and antibiotic sensitivity, however, have made it difficult for them to continue as a choice of probiotic. Some eukaryotic yeasts are being carefully investigated in the search for new and improved alternatives, which could successfully overcome these obstacles. Among some of the strongest candidates to meet these requirements of a future-generation probiotic appears to be the non-pathogenic yeast Saccharomyces boulardii , since a number of its unique characteristics do provide it a significant advantage over its bacterial equivalents currently in use. Several facets of S. boulardii are described in this review, with a focus on explaining how it aids in the treatment of antibiotic-triggered diarrhoea and gastrointestinal inflammation in juveniles, ultimately enhancing and regaining gut health. Owing to its low cost, and safety, S. boulardii is fast emerging as a powerful probiotic for human wellness. Lastly, this review article shed light on possible utilization of yeast probiotic in personalized healthcare to accomplish the maximum degree of robust health and longevity.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: